HKU's Tradition in Virology and Microbiology: From Naming Pathogens to International Honours

Whenever researchers around the world write "HKU1" or "hongkongensis", they are citing an original discovery made at The University of Hong Kong (HKU). This is a form of "signature" built not on ranking tables, but on the letters embedded in scientific names. Behind it lies a chain of institutional foundations — from the HKU-Pasteur Research Centre in 2000 to the State Key Laboratory of Emerging Infectious Diseases (SKLEID) in 2005. This article traces the research platforms that underpin HKU's flagship strength in virology, the pathogens that carry "HKU" in their names, and the international recognition earned by its leading scientists. In keeping with this archive's editorial convention (Category 00–12: neutral factual domain), historically significant and award-winning scientists are named on the basis of verifiable records.

For the chronological narrative of HKU's scientific contributions across successive outbreaks (1997 avian flu, 2003 SARS, 2020 COVID-19), see signature-virology-infection.md. For the broader architecture of State Key Laboratories, see institutes-and-labs.md.

---

# I. The State Key Laboratory of Emerging Infectious Diseases (SKLEID)

According to the official SKLEID / Virology page^※, the laboratory was approved in October 2005 by the Ministry of Science and Technology of China. It was established in recognition of the contributions made by HKU scientists during the SARS response of 2003/2004 and is housed within the medical faculty complex at 21 Sassoon Road, Pokfulam, operating under the umbrella of the LKS Faculty of Medicine / School of Public Health. It was one of the earliest State Key Laboratories established in Hong Kong and remains a flagship platform for the University's scientific research (see also institutes-and-labs.md).

According to the same official page, the laboratory's research encompasses emerging viruses (SARS, avian influenza, etc.), bacteria, fungi, and antimicrobial resistance (AMR), adopting an integrated pathway from surveillance and early warning through to basic, clinical, and translational research. Its published research teams include leading scholars such as Malik Peiris, Guan Yi (管軼), and G. J. D. Smith.

---

# II. The HKU-Pasteur Research Centre / Research Pole

# 2.1 The collaboration with the Institut Pasteur

According to the HKUMed press release "HKU-Pasteur turns 20"^※ and the C2i page^※, the HKU-Pasteur Research Centre is a joint laboratory between HKU and the Institut Pasteur (France), founded in 2000 with the aim of pursuing research and teaching excellence on emerging viruses. The 20th-anniversary press release notes that from the 2003 SARS outbreak onwards, the HKU-Pasteur Research Centre was deeply involved in coronavirus research, consolidating the Faculty of Medicine's leading position in this field. It adopts a "One-Health" approach and has contributed to the global response to influenza, MERS, Ebola, and other diseases. HKU-Pasteur is part of the Institut Pasteur International Network and benefits from the research environment of the School of Public Health.

Note: Details concerning the founding director of the HKU-Pasteur Research Centre (e.g., Antoine Danchin) and the 2013 organisational restructuring (from "Research Centre" to "Research Pole", integrated into the School of Public Health) are recorded in some secondary summaries. However, the specific official pages verified by this archive do not confirm these two points word for word. This article therefore adheres to what is confirmed by those official pages — founded in 2000, a joint venture with the Institut Pasteur, and part of the International Network — and marks the individual name of the founder and the 2013 restructuring as pending further verification.

# 2.2 Succession of leadership (neutral fact)

According to public records, Professor Leo Poon Lit-man succeeded Professor Malik Peiris in July 2020 to a role involving the co-leadership of the relevant WHO-recognised centre and the HKU-Pasteur partnership. Professor Poon's research focuses on the cross-species transmission of viruses from animals to humans (novel influenza, coronaviruses) and the development of their molecular diagnostics, covering pathogens including H5N1, 2009 pandemic H1N1, and H7N9. Since 2006, Professor Poon has been a member of the International Committee on Taxonomy of Viruses (ICTV) Coronavirus Study Group and has served on multiple WHO working groups on emerging viruses.

---

# III. WHO H5 Reference Laboratory

HKU's School of Public Health forms another pillar of its virology flagship. According to public records, HKU's Centre of Influenza Research is one of 12 WHO H5 Reference Laboratories worldwide, responsible for providing international reference services, training, risk assessment, and advice on vaccine strain selection for H5 and other animal influenza viruses with zoonotic potential. This embedding within the "surveillance—reference—early warning" international network positions HKU as a nodal point in the global influenza and coronavirus alert system. The School of Public Health is also a WHO Collaborating Centre for Infectious Disease Epidemiology and Control (since 2014); for details see signature-virology-infection.md §IV.

---

# IV. InnoHK centres in virology and immunology

Among the Health@InnoHK clusters led by HKU, two centres extend directly from its infectious-disease flagship (see also institutes-and-labs.md):

• Centre for Virology, Vaccinology and Therapeutics (CVVT): Focused on virology, vaccines, and therapeutics. According to an HKU press release^※, CVVT and SKLEID jointly developed an intranasal H5N1 avian influenza vaccine — a continuation of the same technical pathway that earlier produced an intranasal COVID-19 vaccine (see signature-virology-infection.md §III for details).
• Centre for Immunology & Infection (C2i): According to the C2i page^※, its network incorporates the HKU-Pasteur Research Pole and is based at the Hong Kong Science Park.

These centres extend HKU's infectious-disease research from the campus laboratory into the government's flagship R&D platforms and towards the translational end of the pipeline.

---

# V. Leading scholars and international recognition: the 2021 Future Science Prize

HKU's virology and microbiology teams have received wide international recognition, the most emblematic being the 2021 Future Science Prize in Life Sciences. According to the official Future Science Prize announcement^※ and HKU's report^※, Professor Kwok-Yung Yuen of the LKS Faculty of Medicine and Professor Joseph Sriyal Malik Peiris at HKU were awarded the prize for their discoveries concerning the aetiological agent of SARS in 2003 and its zoonotic origins, findings which also proved consequential for the fight against COVID-19. The announcement notes that their team treated Hong Kong's first patients in 2003, isolated SARS-CoV-1 from clinical specimens — a step critical to the design of diagnostic reagents and characterisation of the disease — and that Professor Yuen's sustained research on SARS-like viruses in wild bats deepened understanding of zoonotic reservoirs, cross-species barriers, and pathogenesis.

Note: Professor Kwok-Yung Yuen, Professor J. S. Malik Peiris, Professor Guan Yi, Professor Leo Poon, and others are leading scholars in this field. This archive records their names on the basis of neutral and positive academic facts; their scientific contributions, unrelated to any specific administrative role or controversy, are recorded as they stand.

---

# VI. Viruses and bacteria that carry the "HKU" name

A cluster of newly discovered pathogens carries "HKU" or "hongkongensis" directly in its formal scientific name. This is at once a straightforward scientific fact and a distinctive form of "signature" reflecting HKU microbiology's global influence.

# 6.1 Human coronavirus HKU1 (2005)

In the aftermath of SARS in 2003, HKU's microbiology teams intensified their screening of respiratory patients for unknown pathogens — and uncovered an entirely new human coronavirus.

• According to the original paper published in the Journal of Virology (January 2005)^※, the virus was identified by Mr. Patrick C. Y. Woo, Ms. Susanna K. P. Lau, and others from the Department of Microbiology at HKU. The paper was titled "Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia."
• According to the paper and a Wikipedia summary^※, the virus was first detected in a 71-year-old man with pneumonia who had recently returned to Hong Kong from Shenzhen. It was formally named Coronavirus HKU1, the "HKU" standing for The University of Hong Kong.
• According to a retrospective analysis in the same paper^※, the team re-examined nasopharyngeal aspirate samples that had tested "SARS-negative" during the 2003 outbreak and found HKU1 RNA in a sample from a 35-year-old woman with pneumonia — indicating that the virus had already been circulating in the human population, but simply had not been identified until this study.

# 6.2 Bat coronaviruses HKU2–HKU13: a whole family of "HKU" designations

The 2003 SARS outbreak propelled bats to the forefront of research as viral reservoir hosts. HKU's teams subsequently discovered and named a series of novel coronaviruses in bats and other wildlife. According to the Wikipedia biography of Professor Kwok-Yung Yuen^※, in addition to the human coronavirus HKU1, his team has identified bat coronaviruses HKU2 through HKU13 and many other novel viruses, as well as several new bacterial species named after Hong Kong or China.

Background note (compiled from public sources): The systematic numbering of newly discovered viruses with "HKU" plus a serial number is the result of years of methodical sampling, sequencing, and naming by HKU's teams. The institutional foundation for such work is precisely SKLEID, described in §I of this article. The vast majority of these "HKU-numbered" viruses are of animal origin and do not necessarily infect humans, but together they form a vital reference library for understanding coronavirus evolution and cross-species transmission.

# 6.3 Laribacter hongkongensis (2001)

The "Hong Kong signature" does not appear only in the virosphere; HKU's teams have left it in the bacterial world, too. According to research published in the Journal of Clinical Microbiology on its eco-epidemiology^※ and a multi-locus sequence typing study (PMC)^※, Laribacter hongkongensis was first isolated in 2001 from the blood and empyema (pus in the pleural cavity) of a man with alcoholic cirrhosis. It is a Gram-negative, facultatively anaerobic, seagull-shaped bacillus that was subsequently found to be associated with freshwater-fish-related gastroenteritis and traveller's diarrhoea. In territory-wide surveillance, the bacterium was primarily isolated from freshwater fish (with varying detection rates in grass carp, bighead carp, and mud carp), and detection rates were higher in spring and summer than in autumn and winter. Its specific epithet hongkongensis literally means "of Hong Kong" — permanently encoding the place of discovery into the formal name of this novel genus and species.

# 6.4 Why these names matter

The reason these names deserve their own section is this: they capture HKU microbiology's workflow of "systematic sampling — rapid sequencing — formal nomenclature" and freeze it into proper nouns that the global scientific literature can cite, and has cited, over and over again.

---

# VII. Summary and outstanding verifications

• Sourced with confidence: SKLEID (established in 2005 in recognition of SARS contributions); HKU-Pasteur (founded in 2000, a joint venture with the Institut Pasteur, One-Health approach); the WHO H5 Reference Laboratory; InnoHK CVVT and C2i; the 2021 Future Science Prize; and HKU1, HKU2–13, and Laribacter hongkongensis — all are supported by official or academic sources.
• Pending further verification: The individual name of the founder of HKU-Pasteur (e.g., Antoine Danchin) and the 2013 organisational restructuring from "Research Centre" to "Research Pole" have not been confirmed word-for-word by the official pages consulted here; the year of first report and the host species for each individual virus in the HKU2–HKU13 series — the Yuen biography provides only a collective overview, so verifying each one requires consulting the original research papers and virus databases; a complete inventory of pathogens in the "HKU series" requires checking SKLEID and group publication lists; the most up-to-date taxonomic classification of viral and bacterial scientific names should be referenced against official databases.
• Cross-references: For the specific scientific contributions and timeline across successive outbreaks (1997, 2003, 2020), see signature-virology-infection.md; for the overall architecture of State Key Laboratories and InnoHK, see institutes-and-labs.md; for the Faculty of Medicine and Queen Mary Hospital, see ../11-medical-hospital/.

---